REFERENCES
- Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of Hemoglobin: Genetics, Pathopysiology and Clinical Management. Cambridge University Press, Cambridge 2001
- May C, Rivella S, Chadburn A, Sadelain M. Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene. Blood. 2002; 99(6)1902–1908
- Weatherall DJ. Pathophysiology of thalassaemia. Bailliere's Clin Haematol 1998; 11(1)127–146
- Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian Province of Hormozgan. Hemogolobin. 2001; 25(1)35–43
- Fakher R, Bijan K, Taghi AM. Application of diagnostic methods and molecular diagnosis of haemoglobin disorders in Khuzestan province of Iran. Indian J Hum Genet. 2007; 13(1)5–15
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988; 16(3)1215
- Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002; 87(10)1113–1114
- Zahed L. The spectrum of β-thalassemia mutations in the Arab populations. J Biomed Biotech. 2001; 1(3)129–132
- Najmabadi H, Karimi-Nejad R, Sahebjam S. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001; 25(3)285–296
- Weatherall DJ, Clegg JB. Thalassaemia—A global health problem. Nat Med. 1996; 2(8)847–849
- Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the haemoglobinopathies. Bailliere's Clin Haemotol. 1998; 11: 185–214
- Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen years experience of prenatal diagnosis of thalassaemia in Iran. Commun Genet. 2006; 9: 93–97